Login

Lincoln Pharmaceuticals Ltd.

₹565.3

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Lincoln Pharmaceuticals Ltd.

  • NSE : LINCOLN

₹565.3

₹565.3

-0.45 (-0.08%) - 1 Jul 2025 04:25 PM
  • NSE : LINCOLN

About Company

Lincoln Pharmaceuticals Ltd is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets ,Capsules,Injectables,Syrups and Ointments.

Market Cap. ₹ 1,132 Cr.
52 Week - High/Low ₹ 980/499
P/E Ratio 13.75
P/B Ratio 1.91
Enterprise Value ₹ 1,138 Cr.
ROE % 17.04
RSI Value 36.25
EMA 50 572.41
EMA 200 619.04
Market Cap. ₹ 1,132 Cr.
52 Week - High/Low ₹ 980/499
P/E Ratio 13.75
P/B Ratio 1.91
Enterprise Value ₹ 1,138 Cr.
ROE % 17.04
RSI Value 36.25
EMA 50 572.41
EMA 200 619.04
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.